Barclays raised the firm’s price target on Fresenius Medical (FMS) to EUR 39 from EUR 38.50 and keeps an Equal Weight rating on the shares.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FMS:
- Fresenius Medical price target raised to EUR 37.30 from EUR 35.40 at JPMorgan
- Fresenius Medical ADRs initiated with a Buy at Berenberg
- Fresenius Medical Care Reports Strong Q3 2024 Results
- Fresenius Medical Care Unveils New Long-Term Incentive Plan
- Fresenius Medical reports Q3 EPS EUR0.73 vs. EUR0.29 last year